DJIA 18,010.68 -115.44 -0.64%
NASDAQ 5,070.03 -27.95 -0.55%
S&P 500 2,107.39 -13.40 -0.63%
market minute promo

Amgen, Inc. (NASDAQ: AMGN)

156.26 -1.09 (-0.69%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

AMGN $156.26 -0.69%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $156.79
Previous Close $157.35
Daily Range $155.58 - $157.97
52-Week Range $114.93 - $173.60
Market Cap $118.8B
P/E Ratio 21.23
Dividend (Yield) $3.16 (2.0%)
Ex-Dividend Date
Dividend Pay Date
Volume 4,413,217
Average Daily Volume 3,357,776
Current FY EPS $9.58




Drug Makers

Amgen, Inc. (AMGN) Description

A biotechnology company which discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology. Website:

News & Commentary

The Best Business Model in Biotech

Understanding the three components that make up the best business model in biotech could make you a better investor and allow you to identify the sector's strongest stocks.

'Fast Money' Recap: Bristol-Myers' Stock Is Ailing, Health Care on the Rise

Short Sellers Get Even More Ambitious Against Biotech Leaders

Recent Buy: Amgen

PRIMECAP Sells Portions of Its Top Two Stakes

Amgen And AstraZeneca's Deal On Psoriasis Drug Faces Termination

CNBC's Stock Pops & Drops From May 26

Amgen, AstraZeneca End Development Pact; Shares Sink

Amgen's Cholesterol Fighting Drug Receives EU Approval

A Review Of Amgen's AMG 334

Actavis to Continue Selling Namenda IR under Court Ruling - Analyst Blog

See More AMGN News...

AMGN's Top Competitors

AMGN $156.26 (-0.69%)
Current stock: AMGN
GILD $112.27 (-0.51%)
Current stock: GILD
CELG $114.44 (-0.43%)
Current stock: CELG
$0.00 (0.00%)
Current stock: